Cargando…
Mineralocorticoid Receptor Pathway Is a Key Mediator of Carfilzomib-induced Nephrotoxicity: Preventive Role of Eplerenone
Carfilzomib is an irreversible proteasome inhibitor indicated for relapsed/refractory multiple myeloma. Carfilzomib toxicity includes renal adverse effects (RAEs) of obscure pathobiology. Therefore, we investigated the mechanisms of nephrotoxicity developed by Carfilzomib. In a first experimental se...
Autores principales: | Efentakis, Panagiotis, Lamprou, Sofia, Makridakis, Manousos, Barla, Ioanna, Nikolaou, Panagiota-Efstathia, Christodoulou, Andriana, Dimitriou, Costantinos, Kostomitsopoulos, Nikolaos, Ntanasis-Stathopoulos, Ioannis, Theochari, Irene, Gavriatopoulou, Maria, Gakiopoulou, Harikleia, Tasouli, Androniki, Vlahou, Antonia, Gikas, Evangelos, Thomaidis, Nikolaos, Dimopoulos, Meletios-Athanasios, Terpos, Evangelos, Andreadou, Ioanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584194/ https://www.ncbi.nlm.nih.gov/pubmed/36285072 http://dx.doi.org/10.1097/HS9.0000000000000791 |
Ejemplares similares
-
An Untargeted Metabolomics Approach on Carfilzomib-Induced Nephrotoxicity
por: Barla, Ioanna, et al.
Publicado: (2022) -
Metabolomics Point out the Effects of Carfilzomib on Aromatic Amino Acid Biosynthesis and Degradation
por: Barla, Ioanna, et al.
Publicado: (2023) -
Elucidating Carfilzomib’s Induced Cardiotoxicity in an In Vivo Model of Aging: Prophylactic Potential of Metformin
por: Efentakis, Panagiotis, et al.
Publicado: (2021) -
Investigating the Vascular Toxicity Outcomes of the Irreversible Proteasome Inhibitor Carfilzomib
por: Efentakis, Panagiotis, et al.
Publicado: (2020) -
Daratumumab May Attenuate Cardiac Dysfunction Related to Carfilzomib in Patients with Relapsed/Refractory Multiple Myeloma: A Prospective Study
por: Terpos, Evangelos, et al.
Publicado: (2021)